BACK TO BACK LATEST NEWS, Official Website about ,all over the world latest news, Entertainment,Sports,Health,Fashion Hollywood,Bollywood ,Business,Latest Stories,Political news,Stock market news,and Hot news and more other topics
Merck KGaA and Pfizer Inc said on Friday they were ending a late-stage study for their drug to treat a form of ovarian cancer in previously untreated patients.
0 comments:
Post a Comment